FEMY
FEMASYS INCCompany with tickers: FEMY
CIK
1339005
CUSIP
31447E105
Shares Outstanding
59,602,787
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-30 | Canning John Charles | Chief Operating Officer | Award | 150,000 |
| 2026-03-30 | Canning John Charles | Chief Operating Officer | Other | 30,000 |
| 2026-03-19 | Lee-Sepsick Kathy | Director, Chief Executive Officer | Award | 68,244 |
| 2026-03-19 | Eichenbaum Kenneth D. | Director | Award | 102,366 |
| 2026-03-19 | Elefant Dov | Chief Financial Officer | Award | 34,122 |
| 2026-03-19 | Larsen Charles | Director | Award | 34,122 |
| 2026-03-18 | Eichenbaum Kenneth D. | Director | Award | 35,200 |
| 2026-03-18 | Eichenbaum Kenneth D. | Director | Other | 0 |
| 2026-03-18 | Eichenbaum Kenneth D. | Director | Other | 0 |
| 2026-03-18 | Eichenbaum Kenneth D. | Director | Other | 0 |
| 2026-03-18 | Eichenbaum Kenneth D. | Director | Other | 0 |
| 2026-03-18 | Eichenbaum Kenneth D. | Director | Other | 25,010 |
| 2026-03-17 | PharmaCyte Biotech, Inc. | 10% Owner | Other | 0 |
| 2026-03-17 | Silverman Joshua | Director | Other | 0 |
| 2026-02-19 | Lee-Sepsick Kathy | Director, Chief Executive Officer | Award | 447,000 |
| 2026-02-19 | Elefant Dov | Chief Financial Officer | Award | 173,000 |
| 2026-02-02 | Sipos Jeremy Alexander | Chief Technology Officer | Award | 80,000 |
| 2025-12-16 | Sipos Jeremy Alexander | Chief Technology Officer | Other | 46,278 |
| 2025-12-16 | Sipos Jeremy Alexander | Chief Technology Officer | Other | 0 |
| 2025-11-07 | Lee-Sepsick Kathy | Director, Chief Executive Officer | Inheritance | 68,244 |
| 2025-11-07 | Lee-Sepsick Kathy | Director, Chief Executive Officer | Inheritance | 68,244 |
| 2025-11-07 | Lee-Sepsick Kathy | Director, Chief Executive Officer | Inheritance | 68,244 |
| 2025-11-07 | Lee-Sepsick Kathy | Director, Chief Executive Officer | Inheritance | 0 |
| 2025-11-07 | Larsen Charles | Director | Inheritance | 34,122 |
| 2025-11-07 | Larsen Charles | Director | Inheritance | 34,122 |
| 2025-11-07 | Larsen Charles | Director | Inheritance | 0 |
| 2025-11-07 | Larsen Charles | Director | Inheritance | 34,122 |
| 2025-11-07 | Elefant Dov | Chief Financial Officer | Inheritance | 34,122 |
| 2025-11-07 | Elefant Dov | Chief Financial Officer | Inheritance | 0 |
| 2025-11-07 | Elefant Dov | Chief Financial Officer | Inheritance | 34,122 |
| 2025-11-07 | Elefant Dov | Chief Financial Officer | Inheritance | 34,122 |
| 2025-08-27 | Elefant Dov | Chief Financial Officer | Inheritance | 38,828 |
| 2025-08-27 | Elefant Dov | Chief Financial Officer | Inheritance | 38,828 |
| 2025-08-27 | Lee-Sepsick Kathy | Director, Chief Executive Officer | Other | 72,223 |
| 2025-08-27 | Lee-Sepsick Kathy | Director, Chief Executive Officer | Inheritance | 48,535 |
| 2025-08-27 | Lee-Sepsick Kathy | Director, Chief Executive Officer | Inheritance | 48,535 |
| 2025-06-25 | Uzialko Edward R | Director | Award | 17,600 |
| 2025-06-25 | Milnes Alistair | CHIEF OPERATING OFFICER | Award | 17,600 |
| 2025-06-25 | Larsen Charles | Director | Award | 17,600 |
| 2025-06-25 | Silverman Joshua | Director | Award | 17,600 |
| 2025-06-23 | Nicholas Kelley Stinson | Chief Commercial Officer | Award | 100,000 |
| 2025-06-23 | Nicholas Kelley Stinson | Chief Commercial Officer | Other | 80 |
| 2025-06-02 | Elefant Dov | Chief Financial Officer | Inheritance | 19,608 |
| 2025-06-02 | Lee-Sepsick Kathy | Director, Chief Executive Officer | Other | 72,223 |
| 2025-06-02 | Lee-Sepsick Kathy | Director, Chief Executive Officer | Inheritance | 34,314 |
| 2025-06-02 | Larsen Charles | Director | Inheritance | 24,510 |
| 2025-06-02 | Currie Daniel Scott | Chief Operating Officer | Other | 22,223 |
| 2025-06-02 | Currie Daniel Scott | Chief Operating Officer | Inheritance | 19,608 |
| 2025-01-29 | Lee-Sepsick Kathy | Director, Chief Executive Officer | Award | 59,849 |
| 2025-01-28 | Currie Daniel Scott | Chief Operating Officer | Award | 29,184 |
| 2025-01-28 | Thomas Christine E | Chief Reg & Clinical Officer | Award | 55,090 |
| 2025-01-28 | Elefant Dov | Chief Financial Officer | Award | 72,045 |
| 2024-07-12 | Silverman Joshua | Director | Award | 17,600 |
| 2024-07-12 | Larsen Charles | Director | Award | 17,600 |
| 2024-07-12 | Milnes Alistair | CHIEF OPERATING OFFICER | Award | 17,600 |
| 2024-07-12 | Uzialko Edward R | Director | Award | 17,600 |
| 2024-02-12 | Spector Richard D. | Chief Commercial Officer | Award | 100,000 |
| 2024-02-12 | Spector Richard D. | Chief Commercial Officer | Other | 0 |
| 2024-02-01 | Currie Daniel Scott | Chief Operating Officer | Award | 61,900 |
| 2024-02-01 | Elefant Dov | Chief Financial Officer | Award | 84,000 |
| 2024-02-01 | Thomas Christine E | Chief Reg & Clinical Officer | Award | 32,600 |
| 2024-02-01 | Lee-Sepsick Kathy | Director, Chief Executive Officer | Award | 204,900 |
| 2023-11-21 | Silverman Joshua | Director | Other | 0 |
| 2023-11-21 | Silverman Joshua | Director | Award | 17,000 |
| 2023-11-21 | PharmaCyte Biotech, Inc. | 10% Owner | Other | 0 |
| 2023-11-21 | PharmaCyte Biotech, Inc. | 10% Owner | Other | 0 |
| 2023-11-21 | PharmaCyte Biotech, Inc. | 10% Owner | Other | 0 |
| 2023-10-10 | Thomas Christine E | Chief Reg & Clinical Officer | Award | 60,000 |
| 2023-07-03 | Lee-Sepsick Kathy | Director, Chief Executive Officer | Award | 270,400 |
| 2023-07-03 | Elefant Dov | Chief Financial Officer | Award | 105,200 |
| 2023-07-03 | Currie Daniel Scott | Chief Operating Officer | Award | 84,600 |
| 2023-06-21 | Morrissey Anne | Director | Award | 8,500 |
| 2023-06-21 | Larsen Charles | Director | Award | 8,500 |
| 2023-06-21 | Uzialko Edward R | Director | Award | 8,500 |
| 2023-06-21 | Perrow Wendy | Director | Award | 8,500 |
| 2023-06-14 | Kendall Keith J | Director | Award | 17,000 |
| 2023-06-14 | Milnes Alistair | CHIEF OPERATING OFFICER | Award | 17,000 |
| 2023-06-14 | Milnes Alistair | CHIEF OPERATING OFFICER | Other | 0 |
| 2023-06-14 | Kendall Keith J | Director | Other | 0 |
| 2022-10-10 | Thomas Christine E | Chief Reg & Clinical Officer | Award | 50,000 |
| 2022-10-10 | Thomas Christine E | Chief Reg & Clinical Officer | Other | 0 |
| 2022-06-08 | Adams John Q JR | Director | Award | 8,500 |
| 2022-06-08 | Uzialko Edward R | Director | Award | 8,500 |
| 2022-06-08 | Dyett John | Director | Award | 8,500 |
| 2022-06-08 | Perrow Wendy | Director | Award | 8,500 |
| 2022-06-08 | Morrissey Anne | Director | Award | 8,500 |
| 2022-06-08 | Larsen Charles | Director | Award | 8,500 |
| 2022-02-28 | Elefant Dov | Chief Financial Officer | Award | 100,000 |
| 2022-02-28 | Elefant Dov | Chief Financial Officer | Other | 0 |
| 2022-01-25 | Currie Daniel Scott | Chief Operating Officer | Award | 20,000 |
| 2022-01-25 | Perrow Wendy | Director | Award | 17,000 |
| 2022-01-19 | Perrow Wendy | Director | Other | 0 |
| 2021-12-15 | Witte William Benson | Director | Other | 12,191 |
| 2021-12-15 | Dyett John | Director | Other | 3,219,795 |
| 2021-09-01 | Evantash Edward | Chief Medical Officer | Other | 0 |
| 2021-06-23 | Dyett John | Director | Buy | 1,000 |
| 2021-06-22 | Larsen Charles | Director | Other | 10,587 |
| 2021-06-22 | Larsen Charles | Director | Buy | 7,000 |
| 2021-06-22 | Larsen Charles | Director | Other | 10,587 |
| 2021-06-22 | Adams John Q JR | Director | Other | 108,693 |